Pyridine, 2-chloro-3-methoxy-4-nitro-, 1-oxide

Catalog No.: 
ACUIKT702
CAS No.: 
101664-57-7
Molecular Formula: 
C6H5ClN2O4
Molecular Weight: 
204.57
Pyridine, 2-chloro-3-methoxy-4-nitro-, 1-oxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$273.00InquiryInquiry
1g95%$682.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePyridine, 2-chloro-3-methoxy-4-nitro-, 1-oxide
IUPAC Name2-chloro-3-methoxy-4-nitropyridine 1-oxide
MDL No.MFCD27976554
Molecular FormulaC6H5ClN2O4
Molecular Weight204.57
SMILESO=[N+]([O-])C1=CC=[N+](C(Cl)=C1OC)[O-]
InChI KeyNXUDNXIIJONTJS-UHFFFAOYSA-N
SynonymPyridine, 2-chloro-3-Methoxy-4-nitro-, 1-oxide;2-Chlor-3-methoxy-4-nitropyridin-1-oxid
CAS No.101664-57-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACUIKT702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUIKT702 route product structure diagram
    ACUIKT702101664-57-7
Inquiry

2. ACUIKT702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUIKT702 route product structure diagram
    ACUIKT702101664-57-7
Inquiry

3. ACUIKT702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUIKT702 route product structure diagram
    ACUIKT702101664-57-7
Inquiry

Comments (0)